Judith Lionarons

Judith Lionarons


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
JLJudith Lionarons
Judith Lionarons
DHDanique M.J. Hellebrekers
Danique M.J. Hellebrekers
SKSylvia Klinkenberg
Sylvia Klinkenberg
CFCatharina G. Faber
Catharina G. Faber
JVJohan S.H. Vles
Johan S.H. Vles
JHJos G.M. Hendriksen
Jos G.M. Hendriksen

16 May 2019 in Muscle & Nerve
Verified
Journal Article
Open access
PDF file
JLJudith Lionarons
Judith Lionarons
GHGovert Hoogland
Govert Hoogland
RHRuben G. F. Hendriksen
Ruben G. F. Hendriksen
CFCatharina G. Faber
Catharina G. Faber
DHDanique M. J. Hellebrekers
Danique M. J. Hellebrekers
JVJohan S. H. Vles
Johan S. H. Vles
Introduction: With increasing life expectancy, comorbidities become overt in Duchenne muscular dystrophy (DMD). Although micturition problems are common, bladder function is poorly understood in DMD. We studied dystrophin expression and multiple isoform involvement in the bladder during maturation to gain insights into their roles in micturition.Methods: Dystrophin distribution was evaluated in rat bladders by immunohistochemical colocalization with smooth muscle, interstitial, urothelial, and neuronal markers. Protein levels of Dp140, Dp71, and smooth muscle were quantitated by Western blotting of neonatal to adult rat bladders.Results: Dystrophin colocalized with smooth muscle cells and afferent nerve fibers. Dp71 was expressed two‐ to threefold higher compared with Dp140, independently of age. Age‐related muscle mass changes did not influence isoform expression levels.Discussion: Dystrophin is expressed in smooth muscle cells and afferent nerve fibers in the urinary bladder, which underscores that micturition problems in DMD may have not solely a myogenic but also a neurogenic origin. Muscle Nerve 60: 202–210, 2019

30 July 2021 in Life
Verified
Journal Article
Open access
PDF file
JLJudith Lionarons
Judith Lionarons
IGImelda J. M. de Groot
Imelda J. M. de Groot
JFJohanna M. Fock
Johanna M. Fock
SKSylvia Klinkenberg
Sylvia Klinkenberg
DVDesiree M. J. Vrijens
Desiree M. J. Vrijens
JVJohan S. H. Vles
Johan S. H. Vles
Introduction: Lower urinary tract symptoms (LUTS) and gastrointestinal (GI) problems are common in Duchenne muscular dystrophy (DMD), but not systematically assessed in regular care. We aimed to determine the prevalence of bladder and bowel dysfunction (BBD) in DMD patients compared with healthy controls (HC). Methods: The Childhood Bladder and Bowel Dysfunction Questionnaire (CBBDQ) based on the International Rome III criteria and the International Children’s Continence Society was filled out by 57 DMD patients and 56 HC. Additionally, possible associations of BBD with, for example, medication use or quality of life were evaluated in an additional questionnaire developed by experts. Results: In 74% of patients versus 56% of HC ≥ 1 LUTS (n.s.) were reported, 68% of patients versus 39% of HC reported ≥1 bowel symptom (p = 0.002) and 53% of patients versus 30% of HC reported combined LUTS and bowel symptoms (p = 0.019). A negative impact of BBD on daily life functioning was reported by 42% of patients. Conclusions: These data underscore that standard screening for BBD is needed and that the CBBDQ could be of added value to optimize DMD care.

29 October 2021 in Life
Verified
Journal Article
Open access
PDF file
JLJudith Lionarons
Judith Lionarons
GHGovert Hoogland
Govert Hoogland
RSRutger Slegers
Rutger Slegers
HSHellen Steinbusch
Hellen Steinbusch
SCSandra M. H. Claessen
Sandra M. H. Claessen
JVJohan S. H. Vles
Johan S. H. Vles
Background: Gastrointestinal (GI) complaints are frequently noted in aging dystrophinopathy patients, yet their underlying molecular mechanisms are largely unknown. As dystrophin protein isoform 71 (Dp71) is particularly implicated in the development of smooth muscle cells, we evaluated its distribution in the neonatal and adult rat intestine in this study. Methods: Dp71 expression levels were assessed in the proximal (duodenum, jejunum and ileum) and distal (caecum, colon and rectum) intestine by Western blotting and qPCR. In addition, the cellular distribution of total Dp was evaluated in the duodenum and colon by immunohistochemical colocalization studies with alpha-smooth muscle actin (aSMA), Hu RNA binding proteins C and D (HuC/HuD) for neurons and vimentin (VIM) for interstitial cells. Results: In neonatal and adult rats, the distal intestine expressed 2.5 times more Dp71 protein than the proximal part (p < 0.01). This regional difference was not observed in Dp71 mRNA. During both stages, Dp-immunoreactivity was predominant in the muscularis propria, where it co-localized with aSMA and HuC/HuD. Conclusions: In neonatal and adult rats, Dp71 was expressed highest in the distal intestine. Together with the observation that Dp may be expressed by myenteric neurons, this warrants a paradigm shift in the treatment of GI comorbidities.